MicroRNA‑126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‑like kinase 4. [PDF]
Zheng Y +12 more
europepmc +1 more source
Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management. [PDF]
Garvey DR +3 more
europepmc +1 more source
Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. [PDF]
Ma Z, Sun Y, Peng W.
europepmc +1 more source
Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer. [PDF]
Parsyan A, Athwal H, Bhat V, Allan AL.
europepmc +1 more source
Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma. [PDF]
Lee HHY +14 more
europepmc +1 more source
Polo-like kinase 4 and Stromal antigen 3 are not associated with recurrent pregnancy loss caused by embryonic aneuploidy. [PDF]
Yoshihara H +10 more
europepmc +1 more source
Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma. [PDF]
Wang J +8 more
europepmc +1 more source
RETRACTION: Polo-Like Kinase 4 Correlates With Greater Tumor Size, Lymph Node Metastasis, and Confers Poor Survival in Non-Small Cell Lung Cancer. [PDF]
europepmc +1 more source
Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition. [PDF]
Kawakami M +15 more
europepmc +1 more source
Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131). [PDF]
Denu RA +6 more
europepmc +1 more source

